Brain glycogen and Alzheimer’s: what the new study found
Quick answer
Researchers at the Buck Institute for Research on Aging report that glycogen, the stored form of glucose, builds up in the brain in Alzheimer’s disease and appears to interact with tau proteins. A 2025 Nature Metabolism study suggests this may add to neuronal stress. The findings are from animal models, which do not automatically translate to humans.
What if the very fuel our brain relies on is also contributing to its decline in later years?
A new study published in Nature Metabolism (2025) has uncovered a powerful link between sugar storage in the brain and the progression of Alzheimer’s disease—offering a surprising window into prevention and treatment. At Cogmission, we believe this discovery is a game-changer, and it strongly supports the Functional Medicine model we use daily to help people stay sharp, energised, and resilient as they age.
Let’s explore what the science says—and how we translate it into practical action.
New evidence suggests excess brain glycogen can interact with tau, driving neuronal stress—and pointing to new prevention and treatment avenues.
A Groundbreaking Discovery About Glycogen and Tau
Researchers at the Buck Institute for Research on Aging report that glycogen—the stored form of glucose—may play an underappreciated role in brain degeneration. Historically viewed as a backup energy source stored mainly in the liver and muscles, glycogen also accumulates in the brain in Alzheimer’s disease and appears to interact directly with tau proteins, the toxic tangles that characterise the condition.
Here’s the twist: instead of passively sitting in neurons, excess glycogen seems to fuel cellular damage, particularly when it can’t be properly broken down due to disrupted activity of the key enzyme glycogen phosphorylase (GlyP). When tau interrupts GlyP’s function, a vicious cycle follows—glycogen builds up, tau builds up, and neurons struggle to defend themselves against oxidative stress. In animal models, increasing GlyP activity reduced brain-cell damage and extended lifespan.
The Metabolic–Tau Link: A Functional Medicine Perspective
This kind of metabolic insight is central to what we do at Cogmission. The Functional Medicine approach doesn’t treat Alzheimer’s as a one-pathway disease. Instead, we view it as a systems breakdown that can involve inflammation, toxins, metabolic dysfunction, hormonal imbalances, nutrient deficits, and impaired detoxification.
- Glucose control: Dysregulated glucose—even at subclinical levels—drives oxidative stress and inflammation, feeding the tau–glycogen dysfunction.
- Mitochondrial support: Neurons need clean, efficient energy. When sugar metabolism is faulty, mitochondria suffer and the brain’s repair systems falter.
- Dietary interventions: In the study, a low-protein diet enhanced GlyP activity in fruit flies and reduced brain damage. While not a direct human protocol, this aligns with our use of time-restricted eating, fasting-mimicking approaches, and targeted nutrient cycling to nudge brain-protective pathways.
Could GLP-1 Drugs Help?
Intriguingly, the findings connect to interest in GLP-1 agonists (e.g., Ozempic) used for diabetes and weight loss but now under study for Alzheimer’s. These drugs modulate glucose pathways and may enhance brain insulin signalling—again highlighting metabolic health as a pillar of brain longevity. We’re watching this space closely: while medications may play a role, we prioritise lifestyle, nutrition, and natural supports and integrate medications where appropriate within a personalised plan.
How We Turn This Into Action at Cogmission
Our Cognoscopy approach already assesses and supports many of the systems implicated in this research:
- Blood sugar balance: Continuous glucose monitoring (CGM), fasting insulin, HbA1c (average blood sugar over about three months), and C-peptide.
- Neuronal energy metabolism: Mitochondrial testing and organic acid profiles.
- Toxic load & oxidative stress: Heavy-metal and mycotoxin testing, antioxidant status.
- Nutritional sufficiency: Key brain nutrients such as magnesium, B vitamins, omega-3s, and phosphatidylserine.
- Genetic vulnerability: ApoE (apolipoprotein E) genotype, methylation SNPs (single-nucleotide polymorphisms, small gene variations), and detox genes.
- Lifestyle & circadian alignment: Sleep, stress, exercise, and meal timing.
Every brain is different, but the principle is the same: protect neurons by restoring systemic balance.
Final Thoughts: The Brain’s Hidden Sugar Code
This research doesn’t just point to a potential new drug target—it reinforces a core Functional Medicine idea:
“Alzheimer’s is not just a brain disease—it’s a metabolic disease that begins decades before symptoms appear.”
By unravelling the relationship between glycogen, tau, and neuronal health, we can better understand how lifestyle, nutrition, and targeted interventions may help slow—or even turn back—the clock on cognitive decline. At Cogmission, we’re already applying these insights and seeing lives transformed.
Want to know your brain’s metabolic story?
Explore your Cognoscopy options or book a free 20-minute call.
Stay in the Loop
For more stories like this, insights, and practical tips, subscribe to our newsletter.
Research note: Summary adapted from a 2025 Nature Metabolism study and related commentary. Findings in animal models don’t automatically translate to humans; always seek personalised medical advice.
Common questions
Is Alzheimer’s a metabolic disease?
At CogMission, our Functional Medicine view is that Alzheimer’s is not just a brain disease but also a metabolic one that begins decades before symptoms appear. We see it as a systems breakdown that can involve inflammation, toxins, metabolic dysfunction, hormonal imbalances, nutrient deficits and impaired detoxification.
What is brain glycogen and how is it linked to tau?
Glycogen is the stored form of glucose, long seen as a backup energy source mainly in the liver and muscles. Researchers at the Buck Institute for Research on Aging report that in Alzheimer’s it also builds up in the brain and appears to interact with tau proteins. When tau disrupts the enzyme glycogen phosphorylase, both may accumulate, leaving neurons less able to cope with oxidative stress.
Can diet change brain glycogen and brain damage?
In the 2025 Nature Metabolism study, a low-protein diet increased glycogen phosphorylase activity in fruit flies and reduced brain damage. This is not a direct human protocol. We link it to approaches such as time-restricted eating, fasting-mimicking and targeted nutrient cycling.
This article is for general information and isn’t a substitute for personal medical advice. Please speak to your GP (family doctor) or a qualified practitioner before making changes to medication or treatment.